EUVIMEDEUVIMED entdecken
LeserbriefOpen Access

GLP ‐1 agonists and SGLT ‐2 inhibitors in adults with sickle cell disease

Ryan Sun, Anand Srivastava, Vimal K Derebail iD, Jin Han iD, Robert E Molokie, Victor Gordeuk iD, Santosh L Saraf iD

American Journal of Hematology · 2024

DOI: 10.1002/ajh.27348 ↗

Kurz gefasst

Leserbrief in der Zeitschrift American Journal of Hematology, 2024. Verfasst von Ryan Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Sickle Cell Center, Division of Hematology & Oncology, University of Illinois Chicago, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Sodium-Glucose Transporter 2 Inhibitors. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute and chronic organ damage are key drivers of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellSodium-Glucose Transporter 2 InhibitorsHumansAdultMaleFemaleMiddle AgedGlucagon-Like Peptide 1Hypoglycemic AgentsDiabetes Mellitus, Type 2Sodium-Glucose Transporter 2

Substanzen

Sodium-Glucose Transporter 2 InhibitorsGlucagon-Like Peptide 1Hypoglycemic AgentsSodium-Glucose Transporter 2

Autor:innen und Institutionen

  • Sickle Cell Center, Division of Hematology & Oncology, University of Illinois Chicago, Chicago, Illinois, USA.
  • Division of Nephrology, University of Illinois Chicago, Chicago, Illinois, USA.
  • UNC Kidney Center, Division of Nephrology and Hypertension, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Department of Pharmacy Practice, University of Illinois Chicago, Chicago, Illinois, USA.
  • Department of Medicine, Jesse Brown VA Medical Center, Chicago, Illinois, USA.

ORCID-Profile: Vimal K Derebail, Jin Han, Victor Gordeuk, Santosh L Saraf

Förderung

  • NIDDK NIH HHS
  • NHLBI NIH HHS
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Sun, R., Srivastava, A., Derebail, V. K., Han, J., Molokie, R. E., Gordeuk, V., & Saraf, S. L. (2024). GLP ‐1 agonists and SGLT ‐2 inhibitors in adults with sickle cell disease. American Journal of Hematology. https://doi.org/10.1002/ajh.27348

Vancouver

Sun R, Srivastava A, Derebail VK, Han J, Molokie RE, Gordeuk V, et al. GLP ‐1 agonists and SGLT ‐2 inhibitors in adults with sickle cell disease. American Journal of Hematology. 2024. doi:10.1002/ajh.27348

BibTeX
@article{Sun2024,
  author = {Sun, Ryan and Srivastava, Anand and Derebail, Vimal K and Han, Jin and Molokie, Robert E and Gordeuk, Victor and Saraf, Santosh L},
  title = {GLP ‐1 agonists and SGLT ‐2 inhibitors in adults with sickle cell disease},
  journal = {American Journal of Hematology},
  year = {2024},
  doi = {10.1002/ajh.27348}
}
Kostenlos starten →